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Abstract
Our aim was to correlate the activity of matrix metalloproteinases (MMPs) with denaturation and the turnover of collagen in
normal and pathological human tendons. MMPs were extracted from ruptured supraspinatus tendons (ns10), macroscopically
normal (‘control’) supraspinatus tendons (ns29) and normal short head of biceps brachii tendons (ns24). Enzyme activity was
measured using fluorogenic substrates selective for MMP-1, MMP-3 and enzymes with gelatinolytic activity (MMP-2, MMP-9
and MMP-13). Collagen denaturation was determined by a-chymotrypsin digestion. Protein turnover was determined by measuring
the percentage of D-aspartic acid (% D-Asp). Zymography was conducted to identity specific gelatinases. MMP-1 activity was
higher in ruptured supraspinatus compared to control supraspinatus and normal biceps brachii tendons (70.9, 26.4 and 11.5 fmol
ymg tendon, respectively; P-0.001). Gelatinolytic and MMP-3 activities were lower in normal biceps brachii and ruptured
supraspinatus compared to control supraspinatus (gelatinase: 0.18, 0.23 and 0.82 RFUysymg tendon respectively; P-0.001;
MMP-3: 9.0, 8.6 and 55 fmolymg tendon, respectively; P-0.001). Most gelatinase activity was shown to be MMP-2 by
zymography. Denatured collagen was increased in ruptured supraspinatus compared to control supraspinatus (20.4% and 9.9%,
respectively; P-0.001). The % D-Asp content increased linearly with age in normal biceps brachii but not in control supraspinatus
and was significantly lower in ruptured supraspinatus compared to age-matched control tendons (0.33 and 1.09% D-Asp,
respectively; P-0.01). We conclude that the short head of biceps brachii tendons show little protein turnover, whereas control
supraspinatus tendons show relatively high turnover mediated by the activity of MMP-2, MMP-3 and MMP-1. This activity is
thought to represent a repair or maintenance function that may be associated with an underlying degenerative process caused by
a history of repeated injury andyor mechanical strain. After tendon rupture, there was increased activity of MMP-1, reduced
activity of MMP-2 and MMP-3, increased turnover and further deterioration in the quality of the collagen network. Tendon
degeneration is shown to be an active, cell-mediated process that may result from a failure to regulate specific MMP activities in
response to repeated injury or mechanical strain.  2002 Elsevier Science B.V. and International Society of Matrix Biology. All
rights reserved.
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1. Introduction
Lesions of the supraspinatus tendon in the rotator cuff
are extremely common and are major causes of chronic
shoulder pain (Chard and Hazleman, 1987; Leadbetter,
1992). We have previously shown that the collagen
* Corresponding author. Tel.: q44-1223-217458; fax q44-1223-
217838.
E-mail address: gpr@cus.cam.ac.uk (G.P. Riley).
network is qualitatively and quantitatively different in
ruptured supraspinatus tendons: there was a reduced
collagen content, an increased proportion of type III
collagen relative to type I collagen, and higher levels of
hydroxylysine and the collagen cross-links hydroxyly-
sylpyridinoline and lysylpyridinoline compared to nor-
mal supraspinatus (Riley et al., 1994a; Bank et al.,
1999). Similar changes have also been observed in
equine tendons affected by chronic tendinopathy, consis-
tent with the hypothesis that changes in the collagen
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Fig. 1. MMP activities, % D-Asp and percentage denatured collagen in tendon. MMP activities were expressed relative to the tendon dry weight,
either as fentamole (fmol)ymg tendon or relative fluorescence units (RFU)ysymg tendon. Data for the biceps brachii tendon are shown in a–e.
Data for the supraspinatus tendon are shown in f–g. Closed circles represent macroscopically normal ‘control’ tendons and open circles represent
ruptured tendons.
network are an integral part of tendon pathology (Birch
et al., 1998). The changes seen in pathological tendons
have been attributed to a deposition of newly synthesised
collagen molecules showing a different profile of post-
translational modifications (Riley et al., 1994a; Bank et
al., 1999). The altered collagen content in degenerate
and ruptured tendons implies that the mature collagen
network is at least partially removed by proteinases and
this may predispose to tendon rupture.
Collagen type I, the major constituent of the tendon
187G.P. Riley et al. / Matrix Biology 21 (2002) 185–195
matrix, is normally resistant to proteolytic cleavage
(Matrisian, 1990). Collagenases, enzymes of the matrix
metalloproteinase (MMP) family, are among the rela-
tively few enzymes capable of cleaving intact fibrillar
collagen. MMPs with collagenase activity include MMP-
1 (EC 3.4.24.7), MMP-2 (EC 3.4.24.24), MMP-8 (EC
3.4.24.34), MMP-13 (MEROPS ID M10.013) and
MMP-14 (MEROPS ID M10.014) (Nagase and Woes-
sner, 1999; Aimes and Quigley, 1995). Cleavage occurs
at a single locus in the collagen triple helix, creating —34
and — fragments which can then be further degraded by14
a variety of proteinases including the gelatinases, MMP-
2 and MMP-9 (EC 3.4.24.35). Although collagenases
play an important role in rheumatological disorders
associated with cartilage collagen turnover and pathol-
ogy (Shlopov et al., 1997; Konttinen et al., 1998), the
role of collagenolytic enzymes in degenerative tendino-
pathy has not been thoroughly investigated.
In many pathological conditions, there is an imbalance
between the synthesis and degradation of the matrix,
leading to net tissue degradation. The important role of
MMPs in connective tissue turnover is generally accept-
ed: an increase in net MMP activity is likely to indicate
matrix degradation, which may represent part of the
remodelling process in wound healing. Although numer-
ous reports have described increased levels of MMPs in
pathological matrix turnover, most studies have focused
on MMP gene expression levels (as determined by RT-
PCR) or on total amounts of MMPs (as determined by
immunological methods or zymography) rather then on
net enzyme activity. The latter is a much more important
parameter, as MMPs present in the inactive pro-form or
complexed to inhibitors such as TIMPs (Tissue Inhibi-
tors of Matrix Metalloproteinases) do not show proteo-
lytic activity. In addition, only a very few studies
(mainly in cartilage) have investigated the relationship
between the amount of damaged extracellular matrix
components present in situ and net enzyme activity of
specific MMPs (Billinghurst et al., 2000; Dahlberg et
al., 2000; Mort et al., 1993). Furthermore, we are not
aware of any study investigating the relationship
between active MMP levels and the molecular age of
the collagen network.
In this study, fluorogenic substrates were used to
monitor net MMP activity in tendon extracts. This type
of substrate consists of a short amino acid sequence,
recognised by MMPs, to which a fluorophore is attached.
The fluorescence is quenched by an absorbing moiety
(quencher) also coupled to the peptide. Upon cleavage,
quenching is lost, and an increase in fluorescence is
measured proportional to the amount of hydrolysed
substrate (Beekman et al., 1996, 1997, 1999). We have
designed fluorogenic substrates using fluoresceinyDab-
cyl as the fluorophoreyquencher combination (Beekman
et al., 1999); these substrates are approximately 100–
200 times more sensitive than previously used substrates
in which EDANSyDabcyl acted as the fluorophorey
quencher combination (Beekman et al., 1996, 1998,
1999; Brama et al., 1998, 2000). We have developed
formats in which it is possible to determine MMP-1
(collagenase 1) activity, MMP-3 (stromelysin 1) activity
or gelatinolytic (MMP-2, MMP-9 and MMP-13) activ-
ity. Zymography was carried out on the same extracts
to determine the nature of the gelatinolytic activity. The
amount of damaged (denatured) collagen molecules
present in situ was quantified with a recently developed
protocol.
Pentosidine, an advanced glycation end-product
(AGE), has been used as a marker of the biological age
of the collagen network in a wide range of tissues such
as dura mater (Sell and Monnier, 1989; Monnier et al.,
1992), skin (Monnier et al., 1992; Sell and Monnier,
1990; Sell et al., 1993), lens-proteins (Dyer et al., 1991)
and cartilage (Bank et al., 1998; Verzijl et al., 2000a).
It accumulates in a linear fashion with age in the short
head of biceps brachii, a tendon that is rarely affected
by pathology (Bank et al., 1999). However, in the
normal supraspinatus tendon this relationship is not
observed and there is less pentosidine in older tendons
than would be expected for the age of the tendon (Bank
et al., 1999). In addition, significantly lower pentosidine
levels were found in ruptured supraspinatus tendons
compared to age-matched normal supraspinatus. The
most likely explanation is increased remodelling of the
collagen network, with mature collagen being degraded
and replaced with newly synthesised collagen (Bank et
al., 1999). However, although collagen turnover is a key
determinant of pentosidine levels (Verzijl et al., 2000b),
the extent of glycation of long-lived tissue proteins also
depends on the tissue glucose concentration and oxida-
tive stress (Sell and Monnier, 1989). As we know little
about these conditions in biceps brachii tendon and
supraspinatus tendons, a more reliable measurement of
the biological age of the collagen network is required.
Consequently, in this study, the molecular age of matrix
protein was determined by measuring the percentage D-
aspartic acid (% D-Asp). This measure of protein resi-
dence time is based on the relatively fast racemisation
of aspartic acid from the L-form (in which it is built
into proteins) into the D-form (Helfman and Bada, 1975;
Masters and Bada, 1977; Pfeiffer et al., 1995).
2. Results
2.1. D-Aspartic acid racemisation
The percentage D-Asp is a marker of the biological
age of the protein network, and consequently, an indi-
cator of the rate of matrix protein turnover. In biceps
brachii tendons, a linear increase in % D-Asp levels was
seen throughout the entire age range (R s0.83, P-2
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Table 1
Matrix metalloproteinase activities in tendon
Tendon MMP-1 MMP-2y9y13 MMP-3
fmolymg tendon RFUymg tendon fmolymg tendon
Normal biceps brachii 11.5 (8.9) 0.18 (0.23) 9.0 (11)
(ns24)
Control supraspinatus 26.4 (16.9) 0.82 (0.62)** 55.0 (53.0)**
(ns28)
Ruptured supraspinatus 70.9 (29.9)* 0.23 (0.07) 8.6 (6.0)
(ns10)
Values are expressed as mean activity relative to tendon dry weight (S.D.); RFUsrelative fluorescence units.
P-0.001 compared to biceps brachii and control supraspinatus (Mann–Whitney test).*
P-0.001 compared to biceps brachii and ruptured supraspinatus (Mann–Whitney test).**
Table 2
Matrix metalloproteinase activity in old ()60 years) vs. younger tendons
Tendon Age -60 years Age )60 years
MMP-1 MMP-2y9y13 MMP-3 MMP-1 MMP-2y9y13 MMP-3
fmolymg RFUymg fmolymg fmolymg RFUymg fmolymg
Normal biceps brachii 12.3 (10.8) 0.10 (0.05) 6.0 (2.0) 11.0 (7.8) 0.23 (0.28) 12.0 (13.0)
Control supraspinatus 18.9 (10)* 0.91 (0.58) 61.0 (60.0) 36.4 (19.5)** 0.78 (0.69) 51.0 (50)
Values are expressed as mean activity relative to tendon dry weight in milligrams (S.D.); RFUsrelative fluorescence units.
P-0.02 compared to normal biceps brachii tendon (Mann–Whitney test).*
P-0.001 compared to younger (-60) control supraspinatus (Mann–Whitney test).**
0.001; Fig. 1a). In the control supraspinatus tendon, this
relationship was not apparent, particularly in older spec-
imens (Fig. 1f). After the age of 60 years, a large scatter
was observed, mainly because of the low levels in a
substantial number of subjects. Thus, after the age of
60 years, a significant decline in the biological age of
the protein matrix was seen in supraspinatus compared
to biceps brachii tendon (P-0.001). Specimens of
ruptured supraspinatus tendon (Fig. 1f) showed signifi-
cantly lower D-Asp levels (0.33%, ns7) compared to
age-matched specimens (age 55–80 years) of control
supraspinatus (1.09%, ns6, P-0.01) and normal
biceps brachii tendon (1.40%, ns10, P-0.01).
2.2. MMP activities in tendon extracts
The MMP activity assays were previously shown to
be specific for MMP-1, MMP-3 and gelatinolytic activ-
ities (MMP-2yMMP-9yMMP-13), respectively (Beek-
man et al., 1996, 1998, 1999; Brama et al., 1998;
DeGroot et al., 2001) MMPs associated with collagen
turnover were extracted from tendon samples using a
standardised protocol and normalised against the dry
weight of the tendon to enable the comparison of net
enzyme activities between specimens; see Fig. 1 and
Tables 1 and 2.
In the short head of biceps brachii tendons, only low
levels of active MMP-1, MMP-3 and gelatinolytic
MMPs (MMP-2, -9 and -13) were present (Table 1 and
Fig. 1b–d). No changes were observed with respect to
age and there was little inter-individual variation. Sig-
nificantly higher levels of MMP-1, MMP-3 and gelatin-
olytic MMPs were observed in the control supraspinatus
tendons, although there was a large inter-individual
variation (Table 1 and Fig. 1g–i). Mean MMP-1 activ-
ities were significantly higher in older supraspinatus
tendons ()60 years) compared to younger supraspina-
tus, and also higher than those detected in biceps brachii
tendons (Table 2). There were no other significant
differences with respect to age. The ruptured supraspi-
natus tendons showed significantly higher levels of
MMP-1 activity compared to control supraspinatus ten-
dons and biceps brachii tendons (Table 1 and Fig. 1g).
Interestingly, there were significantly lower levels of
gelatinolytic enzymes and MMP-3 in the ruptured
supraspinatus compared to control supraspinatus (Table
1 and Fig. 1h–i); levels of these enzymes were not
significantly different from that of the biceps brachii
tendon. There was a linear relationship between levels
of gelatinolytic activity and the levels of MMP-3 (Fig.
2a,b). No relationships were found between MMP-1 and
MMP-3 activity, in either the biceps brachii tendon or
supraspinatus tendon, and there was no direct correlation
of any single enzyme activity with the % D-Asp (data
not shown).
2.3. Collagen denaturation
Digestion with a-chymotrypsin was used to assay the
proportion of denatured (unwound) collagen in the
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Fig. 2. Correlation between MMP-3 and gelatinase activities in tendon. MMP activities were expressed relative to the tendon dry weight, either
as fentamole (fmol)ymg tendon or relative fluorescence units (RFU)ysymg tendon. Data for the biceps brachii tendon are shown in (a). Data for
the supraspinatus tendon are shown in (b). Closed circles represent macroscopically normal ‘control’ tendons and open circles represent ruptured
tendons.
Fig. 3. Gelatin zymography of tendon extracts. Tendon extracts (5 mg total proteinywell) were subject to electrophoresis in 10% SDS polyacryl-
amide gels containing 1 mgyml gelatin. Purified MMP-2 and MMP-9 standards were loaded at 1 ngywell. After electrophoresis, gels were washed
in 2.5% Triton X-100 (to remove SDS), incubated in development buffer (50 mM Tris (pH 7.5), 5 mM CaCl , 1 mM ZnCl ) for 18 h at 37 8C,2 2
then stained with Coomassie Brilliant Blue R250. Biceps brachii specimens (lanes 3,4) showed only low levels of MMP-2, predominantly in the
pro-form. Control supraspinatus specimens (lanes 5, 6) showed higher levels of MMP-2, with a greater proportion in the active form. Ruptured
supraspinatus (lanes 7, 8) also showed predominantly MMP-2 activity. Levels of the active form correlated with data obtained by the fluorogenic-
peptide assays. MMP-2 and MMP-9 lysis zones were inhibited by addition of 2 mmol ortho-phenanthroline (O-Phe, an inhibitor of MMPs) to
the development buffer (not shown). A band at approximately 40 kDa in the MMP-2 standard and some samples was not inhibited by O-Phe
(was not an MMP) and represents an unknown enzyme with gelatinase activity.
tendon specimens. Previous work has shown that the
removal of proteoglycans and newly synthesised colla-
gen with 4 M guanidine chloride does not irreversibly
denature undamaged collagen, and 90% of the denatured
collagen is retained within the cross-linked mature col-
lagen fibrils (Hollander et al., 1994, 1995; Bank et al.,
1997). The mean proportion of denatured collagen in
the control supraspinatus was 9.9% (range 2.6–16.7%)
and did not change significantly across the age range
from 18 to 96 years (Fig. 1j). There was a significantly
increased proportion of denatured collagen in ruptured
supraspinatus tendons (Fig. 1j), averaging 20.4% of the
total collagen (range 12.8–30.3%, P-0.001). An
increased proportion of denatured collagen was also
found in the biceps brachii tendon samples compared to
control supraspinatus (Fig. 1e), averaging 15.9% of the
total collagen (range 6.5–29.6%; Ps0.01). No relation-
ships were found between the amount of denatured
collagen and the MMP-1, MMP-3 or gelatinolytic activ-
ities (data not shown).
Since the gelatinase activity assay did not discriminate
between MMP-2, MMP-9 and MMP-13, the identity of
the gelatinase was further investigated by gelatin zym-
ography. The major activity on the zymogram in all
tissue samples was associated with MMP-2, and the
relative intensity of the bands correlated with the data
obtained using the peptide substrate (Fig. 3). MMP-2
and MMP-9 activities were confirmed by incorporation
of ortho-phenanthroline (O-Phe, an inhibitor of MMPs)
in the development buffer, which inhibited the major
lysis zones (not shown). An additional minor lysis zone
at approximately 40 kDa in the MMP-2 standard and
some of the samples was not inhibited by O-Phe, and
may represent non-MMP activity.
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3. Discussion
Few studies have attempted to compare net MMP
activity with indices of matrix turnover in connective
tissue pathology, and little was previously known about
the activity and expression of these enzymes in normal
and degenerate tendons. In this study, we have shown
that, similar to osteoarthritic cartilage, degeneration of
the supraspinatus tendon is associated with increased
collagen turnover, potentially mediated by several mem-
bers of the matrix metalloproteinase family. We have
also shown differences in the rate of collagen remodel-
ling between different tendons. The increased rate of
remodelling in control supraspinatus tendons is consis-
tent with a history of previous injury and repair at this
site, and demonstrates the importance of cell activity for
the maintenance of the supraspinatus tendon matrix.
After tendon rupture, there is a change in MMP activity
that leads to a deterioration in the quality of the collagen
network, supporting the concept that early surgical repair
is essential for a good outcome.
The short head of the biceps brachii tendon is rarely
involved in any pathology, and histological studies of
the cadaver material used in this study did not show
significant matrix abnormalities (Chard et al., 1994).
The linear increase in the % D-Asp indicates that the
protein content (which is predominantly collagen) of
the short head of biceps brachii tendon is hardly
renewed; these data are consistent with our previous
study of pentosidine accumulation in the tendon (Bank
et al., 1999). The low turnover is also reflected in the
MMP activity levels: only very low levels of active
MMP-1, MMP-3 and gelatinolytic enzymes were
observed. Despite these low enzyme levels, considerable
amounts of denatured collagen were detected. It is not
known whether these are the result of previous degra-
dation by collagenases, or damage due to mechanical
loading (e.g. due to overloading or fatigue failure). The
cleaved collagen molecules, trapped in the matrix due
to the presence of inter-molecular cross-links (Poole et
al., 1993), remain within the collagen network — most
probably because of the lack of adequate amounts of
gelatinases, enzymes that are essential for the removal
of denatured collagen molecules.
In contrast to the biceps brachii tendon, the supras-
pinatus tendon is frequently affected by degenerative
pathology, and most macroscopically normal supraspi-
natus tendons show microscopic evidence of degenera-
tive change (Chard et al., 1994; Riley et al., 2001). By
using aspartic acid racemisation data as a molecular
clock, we showed that (particularly after the age of 60
years) significant amounts of protein remodelling have
occurred, confirming our previous pentosidine data
(Bank et al., 1999). This represents mainly collagen
turnover, since previous work has shown that there is
no change in the non-collagen component of these
tendon that would account for the observed change in
% D-Asp (Riley et al., 1994b). The D-Asp levels in
normal supraspinatus are sometimes less than 50% of
what would have been expected under conditions of
undisturbed tissue ageing. This is thought likely to
represent a history of repetitive micro-injuries to the
supraspinatus tendon, which are subsequently repaired
by the removal of damaged matrix and the deposition
of newly synthesised collagen. Alternatively, there may
be a process of continual matrix replacement, occurring
in the supraspinatus but not in the short head of biceps
brachii, perhaps as a consequence of the different
mechanical demands placed upon these tendons. In fact,
after the age of 70 years, all D-Asp values are lower
than expected, suggesting that in supraspinatus tendons,
matrix turnover is the rule rather than the exception.
This remodelling could occur by increasing the net level
of active MMPs. Compared to the biceps brachii tendon,
the control supraspinatus showed increased levels of all
MMP activities, particularly in older tendons with
respect to MMP-1 activity, and especially with respect
to gelatinase (MMP-2) activities. As described above,
the gelatinase activity may account for the significantly
lower amount of denatured collagen remaining in the
tissue compared to the biceps brachii tendon, although
other proteinases and phagocytic processes may also be
involved in collagen turnover (Creemers et al., 1998).
In ruptured supraspinatus tendons, we detected an
increase in the amount of denatured collagen, a decrease
in % D-Asp levels and an increase in MMP-1 (collage-
nase 1) enzyme activity compared to control supraspi-
natus tendons. These data are consistent with increased
enzymatic degradation and increased turnover of the
fibrillar collagen network. An increase in the non-
collagen protein component of the ruptured tendon
matrix could account for some of the decrease in % D-
Asp levels. However, since the majority of the protein
even in the ruptured tendon is collagen (Riley et al.,
1994a,b), the data are most likely to reflect increased
collagen turnover, consistent with previous studies of
the pentosidine content (Bank et al., 1999). Although
increased MMP-1 activity has previously been detected
in culture media from explants of ruptured supraspinatus
tendons (Dalton et al., 1995), this is the first study to
measure MMP-1 activity extracted directly from the
tissue. An increase in MMP-1 activity and degradation
of the collagen fibril network is a potential cause of the
weakening of the tendon matrix. We have recently
shown that the amount of denatured collagen molecules
correlates with the loss in tensile stiffness of tissues
(Bank et al., 2000; Wang et al., 2000). The decreased
collagen content (Riley et al., 1994a; Bank et al., 1999),
the change in collagen types (Riley et al., 1994a), the
changed post-translational profile of the deposited col-
lagen (Bank et al., 1999), the increased amount of
denatured collagen and the enhanced expression of
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MMP-1 all may contribute to a mechanically less stable
tendon that is susceptible to rupture. This may explain
why tendon pathology is mostly of a chronic nature,
particularly since the supraspinatus is constantly sub-
jected to considerable forces, due to its role in the
rotator cuff as a dynamic stabiliser of the shoulder joint.
However, it should be pointed out that a study of this
nature cannot rule out the possibility that the changes
in MMP activity and in the collagen network are
secondary to the tendon rupture. The specimens were
taken from close to the site of tendon rupture and may
reflect wound healing rather than changes of degenera-
tive tendinitis. Unfortunately, it was impossible to accu-
rately determine the time interval between tear of the
rotator cuff and the time of operation. However, the
data serve to illustrate that early repair of ruptured
tendon would be preferable before the quality of the
tendon deteriorates excessively.
Another interesting observation to be made is the lack
of correlation between levels of MMP activity and
amounts of denatured collagen. There was also no direct
association between levels of enzyme activity and the
% D-Asp. This discrepancy may arise because other
MMPs and proteinases (such as cathepsins) are poten-
tially involved in tendon collagen turnover, and a pro-
portion is also likely to be degraded by a phagocytic
route (Creemers et al., 1998). However, it is clear that
the measurement of enzyme activity at the time of tissue
sampling does not necessarily reflect previous levels of
enzyme activity and matrix turnover. Consequently,
measurements of the molecular age of the collagen
network (e.g. by pentosidine analysis or D-Asp levels)
or the amount of denatured collagen are very important
since they provide data with regard to previous remod-
elling events in the tissue.
Although the gelatinase assay we used could not
distinguish between MMP-2, MMP-9 and MMP-13, we
were able to confirm the predominance of MMP-2 by
zymography, and the activity detected using fluorogenic
substrates correlated with the intensity of the active
bands seen on the zymogram. Apart from its role in
removing denatured collagen, MMP-2 may also have a
direct role in tendon collagen turnover, since it has
recently been shown to have some activity against triple-
helical type I collagen (Aimes and Quigley, 1995). The
increased activity of MMP-2 in some (not all) macro-
scopically normal (control) supraspinatus is thought to
represent evidence of an underlying pathological proc-
ess, since histopathological studies have shown that
degenerative change is common in cadaver supraspina-
tus tendons (Chard et al., 1994; Riley et al., 2001).
Activity of MMP-2 and matrix degradation has also
been reported in chronic ulcers (Wysocki et al., 1993),
chronic wounds (Bullen et al., 1995) and atherosclerotic
lesions (Li et al., 1996). We have also recently found
up-regulation of MMP-2 gene expression in painful
Achilles tendinopathy, and this activity was associated
with high levels of matrix turnover as determined by
pentosidine cross-link analysis (Ireland et al., 2001 and
unpublished observations). MMP-2 activity is, therefore,
potentially implicated in pathological matrix remodelling
in supraspinatus tendons, even though these tendons
were found to be macroscopically normal (i.e. not
ruptured). The decrease in MMP-2 activity we found in
ruptured tendons may, therefore, be a consequence of
the tendon rupture and not its cause.
MMP-3 (stromelysin) is thought to be an important
enzyme in tissue repair and matrix remodelling, and
increased expression has been associated with cartilage
destruction in osteoarthritis (Okada et al., 1992; Mani-
court et al., 1994) and degenerative disc disease (Nem-
oto et al., 1997). We found a decrease in MMP-3
activity in ruptured tendons compared to control supras-
pinatus, which suggests that MMP-3 has a role in the
maintenance andyor repair of the supraspinatus tendon
architecture. We have recently shown that there is also
a reduction in MMP-3 expression in chronic Achilles
tendinopathy, in lesions where there is no macroscopic
tendon rupture (Ireland et al., 2001). The decrease in
MMP-3 (coupled with an increase in proteoglycan gene
expression) may account for the increased proteoglycan
often found in degenerate tendons (Chard et al., 1994;
Riley et al., 1994b). However, MMP-3 has activity
against a broad range of substrates and is thought to
play a major role in the activation of other MMPs (van
Meurs et al., 1999). Consequently, the reduced activity
of MMP-3 may represent a failure of the normal matrix
remodelling process. The change in enzyme activity
may be a response to repeated injury, although a cell-
mediated response to mechanical load or other factors
(such as tissue hypoxia or hyperthermia) cannot be
ruled out. It is possible that the relatively high rate of
collagen remodelling of the supraspinatus tendon matrix
is induced by the tenocyte response to mechanical load.
A failure to adequately control this response, or exces-
sive load, could potentially result in an imbalance of
proteolytic activities leading to tendon degeneration and
rupture. Further studies are required to investigate how
changes in mechanical load, and the local production of
cytokines and growth factors, modulate specific matrix
metalloproteinase activities in human tendon.
4. Experimental procedures
4.1. Tendon specimens
Macroscopically normal supraspinatus tendons (ns
29, age range 18–96 years) were obtained post-mortem
from cadavers that had no previous history of shoulder
lesions and were processed within 1 h of removal. Many
of these specimens had previously showed microscopic
evidence of degeneration (Chard et al., 1994; Riley et
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al., 2001) and were consequently designated as control
tendons (as opposed to normal). Surgical specimens of
supraspinatus (ns10; age range 55–80 years) were
taken from patients with degenerative ‘tendinitis’ involv-
ing a partial or full thickness tear of the rotator cuff.
Tendon tissue was removed from the margins of the tear
during repair of the rotator cuff during open shoulder
surgery. It was not possible to accurately determine the
time interval between the tear and the time of operation.
All patients had been treated conservatively for some
months prior to surgery, usually involving at least one
injection of corticosteroid into the gleno-humeral joint
space or sub-acromial bursa. Specimens from the short
head of the biceps brachii tendon (ns24, 18–99 years)
were obtained post-mortem and processed within 1 h of
removal. These specimens had previously showed no
microscopic evidence of degeneration (Chard et al.,
1994; Riley et al., 2001) and were designated as normal
tendons. All tendon specimens were dissected free of
extraneous fat and connective tissues, and representative
fragments were freeze dried, powdered in a freezer mill
(SPEX, Glen Creston, Stanmore, England) under liquid
nitrogen and stored desiccated at y20 8C until analysis.
4.2. Fluorogenic substrates; enzyme kinetics




Gly–Lys–NH (TNO-113-F) and Dabcyl–Gaba–Pro–2
Gln–Gly–Leu–Cys–Ala–Lys–NH (TNO211-F);2
Dabcyls4-(4-dimethylaminophenylazo)benzoyl,
Gabasg-amino-n-butyric acid; Nvasnorvaline, Chas
cyclohexylalanine, Abusamniobutyric acid and Smcs
S-methyl-cysteine. The peptides were synthesised on a
10-mmol scale by solid phase strategies on an automated
peptide synthesiser as described previously (Drijfhout et
al., 1996). Fluorescein was coupled to the peptides via
the cystein’s thiol function using iodoacetamide fluores-
cein (Beekman et al., 1999). Recombinant human
MMPs (MMP-1, 2 nM; MMP-2, 0.5 nM; MMP-3, 2
nM; MMP-8, 2 nM; MMP-9, 0.5 nM; MMP-13, 1 nM;
MMP-14, 1 nM) were incubated with 125 nM TNO003-
F, TNO113-F or TNO211-F at 25 8C in 180 ml buffer
A w150 mM Tris pH 7.5, 150 mM NaCl, 5 mM CaCl ,2
1 mM ZnCl , 0.01% (vyv) Brij-35x. The catalytic2
efficiencies (K yK in 10 yMys at 25 8C), determined3cat m
as described previously (Beekman et al., 1996 and
1997), for all available MMPs for TNO003-F are: MMP-
1s0.2, MMP-2s4.0, MMP-3s21.8, MMP-8s0.3,
MMP-9s3.9, MMP-13s10.8 and MMP-14s1.8; for
TNO113-F: MMP1s13.0, MMP-2s30.8, MMP-3s
2.6, MMP-8s63.6, MMP-9s98.2, MMP-13s203.1
and MMP-14s7.1; and for TNO211-F: MMP-1s1.9,
MMP-2s178.9, MMP-3s7.4, MMP-8s42.8, MMP-
9s62.2, MMP-13s617.2 and MMP-14s50.1.
Although the latter substrate, TNO211-F, can be consid-
ered a general MMP-substrate (Beekman et al., 1996,
1998, 1999; Brama et al., 1998) as it is hydrolysed at
reasonable rates by all MMPs tested, and it is preferen-
tially cleaved by MMPs showing gelatinolytic activity.
TNO003-F is most efficiently cleaved by MMP-3. To
enhance the specificity of TNO003-F for MMP-3, a
synthetic MMP inhibitor (CP 138,521) which is less
potent towards MMP-3 was added to the reaction mix-
ture (Beekman et al., 1997). The used inhibitor concen-
tration resulted in a MMP-3 specific activity assay, as
minimal substrate turnover was observed by other
MMPs. Similarly, a convenient MMP-1 specific assay
was obtained by adding a general MMP inhibitor (RS
102,223) that does not inhibit MMP-1 (DeGroot et al.,
2001).
4.3. MMP activity in tendon extracts
A 100-ml sample of extraction buffer wconsisting of
50 mM Tris (pH 7.5), 150 mM NaCl, 5 mM CaCl , 12
mM ZnCl and 0.05% Brijx was added to 1 mg (dry2
weight) of powdered tendon. Extraction of MMPs was
carried out for 1.5 h at ambient temperature under
constant agitation. The supernatant obtained after cen-
trifugation (5 min at 10 000=g) was used for MMP
activity measurements. All incubations were performed
in black round bottom 96 well plates (Dynatech, Den-
kendorf, Germany) in the presence of EDTA-free gen-
eral proteinase inhibitor cocktail Complete (Roche
Diagnostics Ltd, Lewes, UK). The increase in fluores-
cence, resulting from enzyme-mediated cleavage of the
fluorogenic substrates, was monitored at 30 8C in a
Cytofluor 4000 fluorescence reader (PerSeptive Bio-
systems, Framingham, MA, USA) using standard 485
nm (excitation) and 530 nm (emission) bandpass filters.
MMP-1 activity was measured with TNO113-F. A 45-
ml aliquot of supernatant was mixed with 45 ml RS102,
223 (4 mM in buffer A), 45 ml EDTA-free Complete
(a mixture of non-MMP inhibitors; one tablet in 12.5
ml buffer A; Boehringer Mannheim, Germany) and 45
ml TNO113-F (4 mM in buffer A). Incubation was
performed for 2.5 h at 37 8C. The concentration of
active MMP-1 in the supernatants was calculated using
a 0–2 nM calibration curve of human recombinant
MMP-1 and expressed as fmol MMP-1 per mg extracted
tendon. MMP-3 activity was measured with TNO003-F.
Forty-five microlitres of supernatant were added to 45
ml of CP138, 521 (1.2 mM in buffer A), 45 ml EDTA-
free Complete (see above) and 45 ml TNO003-F (10
mM in buffer A) for 4 h at 37 8C. The concentration of
active MMP-3 in the supernatants was calculated using
a calibration curve of 0–8 nM human recombinant
MMP-3 and expressed as fmol MMP-3 per mg extracted
tendon. Gelatinolytic activity (MMP-2, MMP-9 and
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MMP-13) was measured with TNO211-F. To achieve
this, 90 ml supernatant were mixed with 45 ml EDTA-
free Complete (see above) and 45 ml TNO211-F (4
mM in buffer A) and incubated for 3 h at 37 8C. The
amount of gelatinolytic activity in the supernatants was
expressed as the relative increase in fluorescence per
second (DRFUys) per mg tendon.
4.4. Gelatin zymography
Tendon extracts were freeze-dried and the residue was
dissolved in non-reducing SDS sample buffer. An equal
quantity of protein (5 mg), calculated from a protein
assay (BCA protein assay, Perbio Science UK Ltd,
Cheshire, UK), was added to each sample well. Gelatin
zymography was performed under non-reducing condi-
tions using a 10% SDS polyacrylamide gel containing
1 mgyml gelatin (Mini-PROTEAN II system, Bio-Rad
Laboratories Ltd, Hemel Hempstead, UK). MMP-2 and
MMP-9 standards (Chemicon International Ltd, Harrow,
UK) were loaded on each gel (1 ng). Gels were washed
in 2.5% Triton X-100 to remove SDS and allow rena-
turation of MMPs, then transferred to 50 mM Tris (pH
7.5), 5 mM CaCl , 1 mM ZnCl and incubated for 18 h2 2
(37 8C). Pro-MMPs and active MMPs result in white
lysis zones after staining with Coomassie Brilliant Blue
R250, due to gelatin degradation.
4.5. Measurement of denatured collagen
The assay is based on the observation that a-chymo-
trypsin (aCT) digests denatured collagen but not the
intact triple helix of collagen types I, II and III (Hollan-
der et al., 1994, 1995; Bank et al., 1997). In brief, the
powdered tendon was first treated with 4 M GuHCl in
incubation buffer (PBS pH 7.4 containing 1 mM of the
proteinase inhibitors iodoacetamide and EDTA; over-
night, 4 8C) in order to extract proteoglycans and newly
synthesised (non-crosslinked) collagen. After washing
with incubation buffer for 3–6 h at 4 8C, the denatured
collagen present in the tissue was digested overnight at
37 8C with 500 ml incubation buffer containing 0.2 mg
aCTyml. The supernatant (containing the digested col-
lagen) was separated from the remaining insoluble
matrix (containing the intact collagen) and both were
hydrolysed in 6 M HCl in Teflon sealed glass tubes
(110 8C, 20–24 h). The amount of the collagen-specific
amino acid hydroxyproline (Hyp) was measured with
reversed-phase high-performance liquid chromatography
(RP-HPLC) (Bank et al., 1997). The percentage of
damaged (denatured) collagen molecules was calculated
from the amount of Hyp released by aCT divided by
the amount of Hyp present in the tissue before treatment
with aCT.
4.6. Measurement of D-aspartate racemisation (% D-
Asp)
The percentage D-Asp (%D-Asp) was determined by
RP-HPLC according to Aswad (1984) with slight mod-
ifications. In short, tissue samples (1–2 mg) were
digested for 2 h at 65 8C with 5 unitsyml papain (from
Papaya latex; Sigma) in 300 ml of papain buffer w50
mM phosphate buffer (pH 6.5), 2 mM L-cysteine, and
2 mM EDTAx. An aliquot of the papain digests (50 ml)
was subsequently hydrolysed in 1 ml of 6 M HCl at
100 8C for 4 h. After drying, the hydrolysates were
dissolved in 1 ml of 0.1 M sodium borate buffer (pH
9.5) of which 20 ml was derivatised with o-
phthaldialdehydeyN-acetyl-L-cysteine (Sigma) in a
MIDAS autosampler (Spark Holland, Emmen, The
Netherlands). Derivatised D- and L-Asp were separated
on a C18 column (TSKgel ODS-80TM, 150=4.6 mm,
5 mm particle size; TosoHaas, Stuttgart, Germany) at a
flow rate of 0.8 mlymin. Solvent A was 50 mM sodium
acetate (pH 5.9), solvent B was 80% (vyv) methanol
(Rathburn, Walkerburn, UK) and 20% (vyv) solvent A.
Elution of D- and L-Asp was achieved in two steps as
follows: isocratic elution with 9% (vyv) solvent B for
5 min and then a linear increase in the content of solvent
B to 100% over a period of 5 min. The column was
washed for 10 min with 100% solvent B and equilibrated
for 10 min in 9% (vyv) solvent B before injecting the
next sample. Fluorescence was monitored at 340y440
nm. Standard solutions of either D- or L-Asp were
calibrated using non-chiral FMOC (9-fluorenylmethyl
chloroformate) derivatisation as described previously
(Bank et al., 1996) and mixed into standards of known
% D-Asp. All % D-Asp data were corrected for the
amount of D- and L-Asp present in papain (5–10% of
the aspartic acid in the samples) and for racemisation
during the hydrolysis step. The latter was performed by
subtracting the intercept of the graph for % D-Asp vs.
donor age.
4.7. Statistical analysis
Comparison of differences between sample groups
was determined by non-parametric statistics (Mann–
Whitney test) using SPSS software.
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